Compare Biogen Inc (BIIB) vs Box Inc (BOX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Biogen Inc vs Box Inc — how do they compare? Biogen Inc trades at $202.7 (market cap $30.13B), while Box Inc trades at $32.5 (market cap $4.55B). The key difference: Biogen Inc is far larger — about 6.6× Box Inc's market cap. Which is the better fit depends on your goals.
| BIIB | BOX | |
|---|---|---|
Market Cap | $30.13B | $4.55B |
Sector | Health | Technology |
52-Week High | $216.63 | $33.60 |
52-Week Low | $128.93 | $21.37 |
Enterprise Value | $37.20B | $5.10B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →About Box Inc
Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature that enhance workflow management and collaboration.
Read more on BOX →
